HIKMA PHARMACEUTICALS PLC ANNUAL REPORT 2015 Financial Statements Continued Notes to the Consolidated Financial Statements Continued 20.
Trade and other receivables As at 31 December 2015 2014 $m $m Trade receivables 432 384 Prepayments 39 42 VAT and sales tax recoverable 15 12 Employee advances 2 1 488 439 Trade receivables are stated net of provisions for chargebacks and doubtful debts as follows: As at As at 31 December Translation 31 December 2014 Additions Utilisation adjustments 2015 $m $m $m $m $m Chargebacks and other allowances 85 524 524 85 Doubtful debts 35 11 1 2 43 120 535 525 2 128 The following table provides a summary of the age of trade receivables: Past due Not past due on the between between reporting less than 91 and 180 181 and 360 Over one date 90 days days days year Impaired Total At 31 December 2015 $m $m $m $m $m $m $m Total trade receivables as at 31 December 2015 423 50 25 15 4 43 560 Related allowance for doubtful debts 43 43 423 50 25 15 4 517 Chargebacks and other allowances 85 Net receivables 432 Past due Not past due on the between between reporting less than 91 and 180 181 and 360 Over date 90 days days days one year Impaired Total At 31 December 2014 $m $m $m $m $m $m $m Total trade receivables as at 31 December 2014 334 60 26 22 27 35 504 Related allowance for doubtful debts 35 35 334 60 26 22 27 469 Chargebacks and other allowances 85 Net receivables 384 The Group establishes an allowance for impairment that represents its estimate of losses in respect of specific trade and other receivables, where it is deemed that a receivable may not be recoverable.
When the receivable is deemed irrecoverable, the allowance account is writtenoff against the underlying receivable.
More details on the Groups policy for credit and concentration of risk management are provided in Note 30.
